Talia Cohen Solal, PhD

In this episode we dive into mental health. More specifically, the treatment of major depressive disorder, also known as clinical depression. It is an area of tremendous need and one can be very well served through the solutions and approaches that are being developed and being made available to users around the world.

So, how big of a problem is severe depression? More than 300 million people of all ages suffer from depression, and at it’s worse, it can lead to suicide. Fewer than half of those suffering from depression are able to receive treatment due to limited resources, a lack of trained Health care providers, and of course, the social stigma that is still sadly associated with mental disorders.

Start-Up Nation Central

There’s a host of treatment options for depression but the effectiveness of the treatments depend on the type of depression and its severity and, of course, each individual’s adherence and response. Some of the options include Psychotherapy, Psychoeducation and Support Groups, Medications, and Brain Stimulation Therapies. None of these options provide instant relief, and, like in the case of medications, it’s sometimes not known for many weeks if the treatment is effective at all. Antidepressants, for example, often take two to four weeks to begin having an effect, and up to 12 weeks to reach full effect.

With me today is Talia Cohen Solal, PhD, she’s the CEO and co-Founder of Genetika+. Genetika+ is developing a cellular and genetics-based platform to provide meaningful predictions of patient responses to antidepressants. Using biological, environmental and genetic data, they are developing a personalized solution for each patient to help them recover better and faster.


Listen using the embedded player on this page, or

click to subscribe on your favorite podcast app


Today's Topics

  • A quick background of Talia, her work and her on-going research focusing on mental health
  • The current statistics, stages of depression and how it impacts and individual and the society as a whole
  • The current treatment & medication available and how to measure their efficacy
  • How the trial and error approach does a disservice to patients
  • How the ‘Brain in a Dish' can accelerate patients getting onto therapies that produce the outcomes needed.

Are you enjoying our podcasts? Click here to Leave a Review


Dan Kendall

Dan Kendall

ABOUT THE HOST

As an engineer and business leader, I've worked to develop, launch and scale innovative products and solutions that impact health and wellness. As an entrepreneur, I know firsthand what it takes to start a business, build a team, and compete in the global marketplace.

On Digital Health Today, I leverage my experiences to help great leaders and innovators tell their stories and connect to users, investors and other stakeholders.

Connect with me on LinkedIn and Twitter.


Meet our Premier Partners

Digital Health Today would not be possible without our valuable partners.

Cedars-Sinai
Ostendio
Start-Up Nation Central

Learn more about becoming a Premier Partner.

Related